Jessica Reichow

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer”.

Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.09.019

N/A

0.113DataRank · unranked

1 citations

Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, William R. Gwin, Jessica Reichow, Yushe Dang +7 more

Magnitude of antigen-specific T-cell immunity the month after completing vaccination series predicts the development of long-term persistence of antitumor immune response

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-010251

N/A

0DataRank · unranked

1 citations

James Y. Dai, Jessica Reichow, Jong‐Baeck Lim, Katie M Hitchcock-Bernhardt, Sasha E. Stanton +4 more

A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer

Vaccines(2025)10.3390/vaccines13020117

N/A

0DataRank · unranked

5 citations

Lupe G. Salazar, James Y. Dai, Doreen M. Higgins, Andrew L. Coveler, Jennifer S. Childs +7 more